• First UK-based clinical trial focused viral vector manufacturer announces launch pharmatimes
    April 30, 2021
    ViroCell Biologics, the first clinical trial focused viral vector manufacturer in the UK, has announced its official launch, with the aim of becoming the ‘supplier of choice’ for viral vectors and gene modified cells.
  • Introducing ViroCell Biologics contractpharma
    April 29, 2021
    ViroCell Biologics, founded in the UK by a prolific academic viral vector manufacturing team, has officially launched. Viral vectors are the primary delivery method for innovative vaccines such as the Oxford/Astra Zeneca COVID vaccine, as well as ...
PharmaSources Customer Service